P704: ASCIMINIB PROVIDES DURABLE MOLECULAR RESPONSES IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP) WITH THE T315I MUTATION: UPDATED EFFICACY AND SAFETY DATA FROM A PHASE I TRIAL. (23rd June 2022) - Hughes, T.; Cortes, J. E.; Réa, D.; Mauro, M. J.; Hochhaus, A.; Kim, D.-W.; Sasaki, K.; Lang, F.; Heinrich, M. C.; Breccia, M.; Deininger, M.; Goh, Y.-T.; et al.